STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE: Form 990, tax year 2015

View the entire original 990 at ProPublica ↗

Organization
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (EIN 51-0197108)
Tax period
2015-07-01 to 2016-06-30
Filed
2017-05-15
IRS object ID
201711359349305156
Schema version
2015v3.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2017-05-15T11:28:22-05:00ReturnTs
Tax Period End2016-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1ERNST & YOUNG US LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line14370 LA JOLLA VILLAGE DR 500AddressLine1Txt
CityLA JOLLACityNm
State AbbreviationCAStateAbbreviationCd
ZIP92122ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2015-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN510197108EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1SANFORD BURNHAM PREBYS MEDICAL DISCOVERYBusinessNameLine1Txt
Business Name Line2INSTITUTEBusinessNameLine2Txt
FieldValueIRS element (for citing)
In Care Of% GARY CHESSUMInCareOfNm
Business Name ControlSANFBusinessNameControlTxt
Phone8586463100PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line110901 NORTH TORREY PINES ROADAddressLine1Txt
CityLa JollaCityNm
State AbbreviationCAStateAbbreviationCd
ZIP92037ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonGARY CHESSUMPersonNm
Person TitleCFOPersonTitleTxt
Phone8586463100PhoneNum
Signature2017-05-12SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonDEBRA HEISKALAPreparerPersonNm
PTINP00649485PTIN
Phone8585357200PhoneNum
FieldValueIRS element (for citing)
Tax2015TaxYr
Build TS2021-01-29 14:40:06ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerPERRY NISEN MD PHDPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line110901 NORTH TORREY PINES ROADAddressLine1Txt
CityLA JOLLACityNm
State AbbreviationCAStateAbbreviationCd
ZIP92037ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$605,349,211GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.SBPDISCOVERY.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1976FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionSEE SCHEDULE OActivityOrMissionDesc
Voting Members Governing Body23VotingMembersGoverningBodyCnt
Voting Members Independent21VotingMembersIndependentCnt
Total Employee1015TotalEmployeeCnt
Total Volunteers22TotalVolunteersCnt
Total Gross UBI$1,823,328TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$52,137NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$244,026,040PYContributionsGrantsAmt
CY Contributions Grants$112,687,922CYContributionsGrantsAmt
PY Program Service Revenue$906,508PYProgramServiceRevenueAmt
CY Program Service Revenue$1,984,033CYProgramServiceRevenueAmt
PY Investment Income$2,116,377PYInvestmentIncomeAmt
CY Investment Income$9,787,422CYInvestmentIncomeAmt
PY Other Revenue$8,097,885PYOtherRevenueAmt
CY Other Revenue$4,645,694CYOtherRevenueAmt
PY Total Revenue$255,146,810PYTotalRevenueAmt
CY Total Revenue$129,105,071CYTotalRevenueAmt
PY Grants And Similar Paid$0PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$77,062,612PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$77,528,317CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$261,304PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$1,831,412CYTotalFundraisingExpenseAmt
PY Other Expenses$74,570,051PYOtherExpensesAmt
CY Other Expenses$64,840,277CYOtherExpensesAmt
PY Total Expenses$151,893,967PYTotalExpensesAmt
CY Total Expenses$142,368,594CYTotalExpensesAmt
PY Revenues Less Expenses$103,252,843PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$13,263,523CYRevenuesLessExpensesAmt
Total Assets BOY$427,646,063TotalAssetsBOYAmt
Total Assets EOY$517,058,113TotalAssetsEOYAmt
Total Liabilities BOY$95,314,852TotalLiabilitiesBOYAmt
Total Liabilities EOY$207,862,462TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$332,331,211NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$309,195,651NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSEE SCHEDULE OMissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$117,405,286ExpenseAmt
Grant$0GrantAmt
Revenue$2,561,288RevenueAmt
DescSEE SCHEDULE ODesc
Total Program Service Expenses$117,405,286TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsYes (true)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesfalseReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtfalseConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficeYes (true)ForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsfalseGrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsYes (true)TaxExemptBondsInd
Invest Tax Exempt BondsfalseInvestTaxExemptBondsInd
Escrow AccountfalseEscrowAccountInd
On Behalf Of IssuerfalseOnBehalfOfIssuerInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingYes (true)LoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With Officer EntfalseBusinessRlnWithOfficerEntInd
Deductible Non Cash ContrifalseDeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityYes (true)RelatedEntityInd
Related Organization Ctrl EntYes (true)RelatedOrganizationCtrlEntInd
Transaction With Control EntfalseTransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document249IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee1015EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members23GoverningBodyVotingMembersCnt
Independent Voting Member21IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonGARY CHESSUMPersonNm
Phone8586463100PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line110901 N TORREY PINES ROADAddressLine1Txt
CityLA JOLLACityNm
State AbbreviationCAStateAbbreviationCd
ZIP92037ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (31 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
DAVID DOWN
TRUSTEE1.00.0Yes (X)$0$0$0
WILLIAM GERHART
TRUSTEE1.00.0Yes (X)$0$0$0
RASESH THAKKAR
TRUSTEE1.00.0Yes (X)$0$0$0
LUDER WHITLOCK
TRUSTEE1.00.0Yes (X)$0$0$0
LORENZO BERHO
TRUSTEE1.00.0Yes (X)$0$0$0
JAMES BLAIR
VICE CHAIRMAN1.00.0Yes (X)$0$0$0Yes (X)
DANIEL EPSTEIN
TRUSTEE1.00.0Yes (X)$0$0$0
WAINWRIGHT FISHBURN
TRUSTEE1.00.0Yes (X)$0$0$0
PAULINE FOSTER
TRUSTEE1.00.0Yes (X)$0$0$0
PATRICK GERAGHTY
TRUSTEE1.00.0Yes (X)$0$0$0
ALAN GLEICHER
TRUSTEE1.00.0Yes (X)$0$0$0
JEANNE HERBERGER
TRUSTEE1.00.0Yes (X)$0$0$0
DONALD JERNIGAN
TRUSTEE1.00.0Yes (X)$0$0$0
DOUG MANCHESTER
TRUSTEE1.00.0Yes (X)$0$0$0
EDWARD SCHULAK
TRUSTEE1.00.0Yes (X)$0$0$0
STUART TANZ
TRUSTEE1.00.0Yes (X)$0$0$0
CAROL GALLAGHER
TRUSTEE1.00.0Yes (X)$0$0$0
GREG LUCIER
TRUSTEE1.00.0Yes (X)$0$0$0
KRISTIINA VUORI MD PHD
PRESIDENT50.00.0Yes (X)$2,666,889$0$112,645Yes (X)
PERRY NISEN MD PHD
CEO50.00.0Yes (X)$1,111,930$0$336,252Yes (X)
HENRY NORDOFF
TRUSTEE1.00.0Yes (X)$0$0$0
DOUGLAS OBENSHAIN
TRUSTEE1.00.0Yes (X)$0$0$0
BERNARD MACHEN
CHAIRMAN1.00.0Yes (X)$0$0$0Yes (X)
GARY CHESSUM
CFO50.00.0$325,857$0$5,855Yes (X)
GARY RAISL ED D
EVP/CAO/CFO/TREAS (OUTGOING)50.00.0$463,475$0$34,830Yes (X)
KNOX BELL
SECRETARY2.00.0$0$0$0Yes (X)
GARTH POWIS PHD
CENTER DIRECTOR50.00.0$548,622$0$37,785Yes (X)
DANIEL KELLY MD
CNTR DIR/SCI DIR AT LK NONA50.00.0$537,617$0$45,718Yes (X)
ZE'EV RONAI
SCIENTIFIC DIRECTOR50.00.0$333,540$0$44,002Yes (X)
CARL WARE PHD
CENTER DIRECTOR, IIDC50.00.0$439,854$0$39,071Yes (X)
MICHAEL JACKSON PHD
DRUG DISCOVERY & DEV, SR VP50.00.0$456,626$0$43,695Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$6,884,410TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$699,853TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K130IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
DELOITTE TOUCHE LLP
655 WEST BROADWAY SUITE 700SAN DIEGOCA92101AUDIT AND CONSULTING$699,047
DLA PIPER US LLP
PO BOX 64029BALTIMOREMD21264LEGAL$496,299
ARMADA ADMINISTRATORS
PO BOX 37769BALTIMOREMD21297CONSULTING-INSURANCE$450,095
STEVEN K BRAUER
2221 CAMINO DEL RIO S SUITE 300SAN DIEGOCA92108CONSULTING-BUS. DEV.$245,245
BERMAN PROPERTY MANAGEMENT
721 VERONA STREETKISSIMMEEFL34741PROPERTY MANAGEMENT$227,745
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K12CntrctRcvdGreaterThan100KCnt
Federated Campaigns$0FederatedCampaignsAmt
Membership Dues$0MembershipDuesAmt
Fundraising$832,098FundraisingAmt
Related Organizations$0RelatedOrganizationsAmt
Government Grants$66,338,585GovernmentGrantsAmt
All Other Contributions$45,517,239AllOtherContributionsAmt
Noncash Contributions$0NoncashContributionsAmt
Total Contributions$112,687,922TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescSHARED SERVICES REVENUEDesc
Business541990BusinessCd
Total Revenue Column$1,984,033TotalRevenueColumnAmt
Related Or Exempt Func Income$1,984,033RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$1,984,033TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$3,135,455TotalRevenueColumnAmt
Unrelated Business Revenue-$6,042UnrelatedBusinessRevenueAmt
Exclusion$3,141,497ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$7,368TotalRevenueColumnAmt
Exclusion$7,368ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,125,290TotalRevenueColumnAmt
Exclusion$2,125,290ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$258,038RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$258,038RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$258,038TotalRevenueColumnAmt
Exclusion$258,038ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$482,699,330SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$476,054,731SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$6,644,599SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$6,644,599TotalRevenueColumnAmt
Exclusion$6,644,599ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$45,150FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$832,098ContriRptFundraisingEventAmt
Fundraising Direct Expenses$189,409FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$144,259TotalRevenueColumnAmt
Exclusion-$144,259ExclusionAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmtExclusionExclusionAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
RESEARCH541700$1,829,370$1,829,370$0
OTHER RESEARCH SUPPORT541990$208,045$0$0$208,045
SALE OF REAGENTS541990$64,132$0$0$64,132

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$305,078TotalRevenueColumnAmt
Related Or Exempt Func Income$305,078RelatedOrExemptFuncIncomeAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$2,406,625OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$129,105,071TotalRevenueColumnAmt
Related Or Exempt Func Income$2,561,288RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$1,823,328UnrelatedBusinessRevenueAmt
Exclusion$12,032,533ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$3,584,703TotalAmt
Program Services$237,062ProgramServicesAmt
Management And General$3,347,641ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$58,397,347TotalAmt
Program Services$47,973,116ProgramServicesAmt
Management And General$9,374,837ManagementAndGeneralAmt
Fundraising$1,049,394FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$3,873,972TotalAmt
Program Services$3,217,835ProgramServicesAmt
Management And General$606,141ManagementAndGeneralAmt
Fundraising$49,996FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$8,135,849TotalAmt
Program Services$6,812,027ProgramServicesAmt
Management And General$1,204,963ManagementAndGeneralAmt
Fundraising$118,859FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$3,536,446TotalAmt
Program Services$2,748,283ProgramServicesAmt
Management And General$715,861ManagementAndGeneralAmt
Fundraising$72,302FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$1,534,442TotalAmt
Program Services$844,795ProgramServicesAmt
Management And General$683,773ManagementAndGeneralAmt
Fundraising$5,874FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$1,086,661TotalAmt
Program Services$47,704ProgramServicesAmt
Management And General$1,038,815ManagementAndGeneralAmt
Fundraising$142FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$366,170TotalAmt
Program Services$0ProgramServicesAmt
Management And General$366,170ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$195,400TotalAmt
Program Services$0ProgramServicesAmt
Management And General$195,400ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt
Fundraising$0FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$19,246TotalAmt
Program Services$0ProgramServicesAmt
Management And General$19,246ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$952,032TotalAmt
Program Services$518,959ProgramServicesAmt
Management And General$420,724ManagementAndGeneralAmt
Fundraising$12,349FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$40,776TotalAmt
Program Services$10,985ProgramServicesAmt
Management And General$9,559ManagementAndGeneralAmt
Fundraising$20,232FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$8,212,293TotalAmt
Program Services$7,475,191ProgramServicesAmt
Management And General$650,838ManagementAndGeneralAmt
Fundraising$86,264FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$1,297,036TotalAmt
Program Services$960,885ProgramServicesAmt
Management And General$303,392ManagementAndGeneralAmt
Fundraising$32,759FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$13,666,798TotalAmt
Program Services$12,214,014ProgramServicesAmt
Management And General$1,342,832ManagementAndGeneralAmt
Fundraising$109,952FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$565,634TotalAmt
Program Services$469,924ProgramServicesAmt
Management And General$87,540ManagementAndGeneralAmt
Fundraising$8,170FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$1,225,902TotalAmt
Program Services$943,532ProgramServicesAmt
Management And General$260,859ManagementAndGeneralAmt
Fundraising$21,511FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$5,177,017TotalAmt
Program Services$4,366,294ProgramServicesAmt
Management And General$770,762ManagementAndGeneralAmt
Fundraising$39,961FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$12,710,838TotalAmt
Program Services$11,389,200ProgramServicesAmt
Management And General$1,232,173ManagementAndGeneralAmt
Fundraising$89,465FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$101,636TotalAmt
Program Services$0ProgramServicesAmt
Management And General$101,636ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
RESEARCH SUPPLIES & SERV.$12,961,698$12,961,698
SCIENTIFIC COLLABORATIONS$3,863,964$3,863,964$0$0
RECRUITMENT$544,344$250,798$279,054$14,492
BAD DEBT$95,594$95,594

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$222,796TotalAmt
Program Services$99,020ProgramServicesAmt
Management And General$24,086ManagementAndGeneralAmt
Fundraising$99,690FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$142,368,594TotalAmt
Program Services$117,405,286ProgramServicesAmt
Management And General$23,131,896ManagementAndGeneralAmt
Fundraising$1,831,412FundraisingAmt

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,340,667BOYAmt
EOY$4,123,683EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$31,300,615BOYAmt
EOY$23,499,833EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$68,063,217BOYAmt
EOY$60,764,502EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$766,396BOYAmt
EOY$1,160,298EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$1,215,635BOYAmt
EOY$1,184,978EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$6,164,603BOYAmt
EOY$1,596,813EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$279,777BOYAmt
EOY$214,481EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$9,324,340BOYAmt
EOY$6,963,036EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$302,370,550LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$163,206,885LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$139,452,521BOYAmt
EOY$139,163,665EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$166,920,503BOYAmt
EOY$263,938,102EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$11,800,000EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$2,817,789BOYAmt
EOY$2,648,722EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$427,646,063BOYAmt
EOY$517,058,113EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$21,187,228BOYAmt
EOY$18,662,124EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$7,053,695BOYAmt
EOY$124,792,172EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$67,073,929BOYAmt
EOY$64,408,166EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$95,314,852BOYAmt
EOY$207,862,462EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$138,824,388BOYAmt
EOY$138,987,303EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$179,491,957BOYAmt
EOY$156,181,232EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$14,014,866BOYAmt
EOY$14,027,116EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$332,331,211BOYAmt
EOY$309,195,651EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$427,646,063BOYAmt
EOY$517,058,113EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$13,263,523ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$9,872,037NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts$0DonatedServicesAndUseFcltsAmt
Investment Expense$0InvestmentExpenseAmt
Prior Period Adjustments$0PriorPeriodAdjustmentsAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$156,880,684CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$146,497,371CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$146,698,221CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$244,026,040CurrentTaxYearMinus1YearAmt
Current Tax Year$112,703,072CurrentTaxYearAmt
Total$806,805,388TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$156,880,684CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$146,497,371CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$146,698,221CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$244,026,040CurrentTaxYearMinus1YearAmt
Current Tax Year$112,703,072CurrentTaxYearAmt
Total$806,805,388TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$95,508,970SubstantialContributorsTotAmt
Public Support Total170$711,296,418PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$4,402,201CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$4,000,400CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$4,044,153CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$6,992,391CurrentTaxYearMinus1YearAmt
Current Tax Year$5,532,193CurrentTaxYearAmt
Total$24,971,338TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus3 Years$144,833CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$195,599CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$160,548CurrentTaxYearMinus1YearAmt
Current Tax Year$52,137CurrentTaxYearAmt
Total$553,117TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt
FieldValueIRS element (for citing)
Total Support$832,329,843TotalSupportAmt
Gross Receipts Rltd Activities$8,484,609GrossReceiptsRltdActivitiesAmt
Public Support CY1700.85459PublicSupportCY170Pct
Public Support PY1700.88593PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Total Grassroots LobbyingTotalGrassrootsLobbyingGrp
Total Direct LobbyingTotalDirectLobbyingGrp
Total Lobbying ExpendTotalLobbyingExpendGrp
Other Exempt Purpose ExpendOtherExemptPurposeExpendGrp
Total Exempt Purpose ExpendTotalExemptPurposeExpendGrp
Lobbying Nontaxable AmountLobbyingNontaxableAmountGrp
Grassroots NontaxableGrassrootsNontaxableGrp
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp
VolunteersfalseVolunteersInd
Paid Staff Or ManagementfalsePaidStaffOrManagementInd
Media AdvertisementsfalseMediaAdvertisementsInd
Media Advertisements$0MediaAdvertisementsAmt
Mailings MembersfalseMailingsMembersInd
Mailings Members$0MailingsMembersAmt
Publications Or BroadcastfalsePublicationsOrBroadcastInd
Publications Or Broadcast$0PublicationsOrBroadcastAmt
Grants Other OrganizationsfalseGrantsOtherOrganizationsInd
Grants Other Organizations$0GrantsOtherOrganizationsAmt
Direct Contact LegislatorsYes (true)DirectContactLegislatorsInd
Direct Contact Legislators$104,704DirectContactLegislatorsAmt
Rallies DemonstrationsfalseRalliesDemonstrationsInd
Rallies Demonstrations$0RalliesDemonstrationsAmt
Other ActivitiesYes (true)OtherActivitiesInd
Other Activities$182,093OtherActivitiesAmt
Total Lobbying Expenditures$286,797TotalLobbyingExpendituresAmt
Not Described Section501c3falseNotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE C, PART II-B, LINE 1GLOBBYING ACTIVITIES CONTACT AND MEET WITH FEDERAL AND STATE LEGISLATORS AND THEIR STAFF TO SEEK POTENTIAL RESEARCH FUNDING.
SCHEDULE C, PART II-B, LINE 1IOTHER ACTIVITIES DUES TO RESEARCH AND BIOMEDICAL ORGANIZATIONS, A PORTION OF WHICH ARE CONSIDERED LOBBYING. THE INSTITUTE UTILIZES ATLANTIC STRATEGIES GROUP, LLC FOR REPRESENTATION IN WASHINGTON DC, TO INVESTIGATE AND SEEK POTENTIAL FEDERAL RESEARCH FUNDING OPPORTUNITIES OUTSIDE THE TRADITIONAL NIH PROCESS. THE INSTITUTE CONTRACTS WITH CAPITAL INSIGHT AND ASSOCIATES FOR REPRESENTATION IN TALLAHASSEE, FL, TO INVESTIGATE AND SEEK POTENTIAL STATE RESEARCH FUNDING OPPORTUNITIES.

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$26,693,919BeginningYearBalanceAmt
Contributions$510,067ContributionsAmt
Investment Earnings Or Losses-$3,125InvestmentEarningsOrLossesAmt
Other Expenditures$1,213,220OtherExpendituresAmt
End Year Balance$25,987,641EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$26,870,514BeginningYearBalanceAmt
Contributions$920,000ContributionsAmt
Investment Earnings Or Losses$36,749InvestmentEarningsOrLossesAmt
Other Expenditures$1,133,344OtherExpendituresAmt
End Year Balance$26,693,919EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$22,805,011BeginningYearBalanceAmt
Contributions$1,310,000ContributionsAmt
Investment Earnings Or Losses$3,778,222InvestmentEarningsOrLossesAmt
Other Expenditures$1,022,719OtherExpendituresAmt
End Year Balance$26,870,514EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$21,200,471BeginningYearBalanceAmt
Contributions$9,000ContributionsAmt
Investment Earnings Or Losses$2,517,312InvestmentEarningsOrLossesAmt
Other Expenditures$921,772OtherExpendituresAmt
End Year Balance$22,805,011EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$21,602,848BeginningYearBalanceAmt
Contributions$29,575ContributionsAmt
Investment Earnings Or Losses$961,439InvestmentEarningsOrLossesAmt
Other Expenditures$1,393,391OtherExpendituresAmt
End Year Balance$21,200,471EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.45960BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.50080PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.03960TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$25,793,087OtherCostOrOtherBasisAmt
Book Value$25,793,087BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$165,328,062OtherCostOrOtherBasisAmt
Depreciation$73,278,686DepreciationAmt
Book Value$92,049,376BookValueAmt
FieldValueIRS element (for citing)
Leasehold ImprovementsLeaseholdImprovementsGrp

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$110,504,651OtherCostOrOtherBasisAmt
Depreciation$89,928,199DepreciationAmt
Book Value$20,576,452BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$744,750OtherCostOrOtherBasisAmt
Book Value$744,750BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$139,163,665TotalBookValueLandBuildingsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt
Total Liability$0TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$119,214,000TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$9,872,037NetUnrealizedGainsInvstAmt
Other Revenue$212OtherRevenueAmt
Revenue Not Reported-$9,871,825RevenueNotReportedAmt
Revenue Subtotal$129,085,825RevenueSubtotalAmt
Investment Expenses Not Incld$19,246InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$19,246RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$129,105,071TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$142,349,000TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$0OtherExpensesIncludedAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$142,349,000ExpensesSubtotalAmt
Investment Expenses Not Incld2$19,246InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$348OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$19,594ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$142,368,594TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE D, PART V, LINE 4INTENDED USES OF THE ORGANIZATION'S ENDOWMENT FUNDS THE INSTITUTE'S ENDOWMENT FUNDS ARE ESTABLISHED FOR VARIOUS PURPOSES: SCIENTIFIC RESEARCH, ALS RESEARCH, CEO CHAIR, PRESIDENTIAL CHAIR, LEADERSHIP CHAIR IN CANCER RESEARCH, AND UNRESTRICTED AS TO INCOME.
SCHEDULE D, PART X, LINE 2FIN 48 (ASC 740) FOOTNOTE THE INSTITUTE HAS NO MATERIAL DEFERRED TAX ASSETS OR DEFERRED TAX LIABILITIES RECORDED AS OF JUNE 30, 2016 AND 2015. THE INSTITUTE DID NOT RECOGNIZE A CHANGE IN LIABILITY FOR UNRECOGNIZED TAX BENEFITS (THE DIFFERENCE BETWEEN A TAX POSITION TAKEN, OR EXPECTED TO BE TAKEN, IN A TAX RETURN AND THE BENEFIT RECOGNIZED AND MEASURED IN THE FINANCIAL STATEMENTS). THERE WERE NO LIABILITIES FOR UNRECOGNIZED TAX BENEFITS AT JUNE 30, 2016 AND 2015.
SCHEDULE D, PART XI, LINE 2DROUNDING - 212
SCHEDULE D, PART XII, LINE 4BROUNDING - 348

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (7 entries)

RegionRegionTxtEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Europe (Including Iceland and Greenland)44Program servicesSEE PART V$120,924
East Asia and the Pacific14Program servicesSEE PART V$31,988
North America1Program servicesSEE PART V$647
South America1Program servicesSEE PART V$1,225
Middle East and North Africa3Program servicesSEE PART V$1,812
Russia and the Newly Independent States2Program servicesSEE PART V$1,306
South America3Program servicesSEE PART V$4,156
FieldValueIRS element (for citing)
Subtotal Employees68SubtotalEmployeesCnt
Total Employee68TotalEmployeeCnt
Subtotal Spent$162,058SubtotalSpentAmt
Total Spent$162,058TotalSpentAmt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE F, PART I, LINE 3PROCEDURES FOR MONITORING USE OF GRANTS SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE DOES NOT MAINTAIN ONGOING OPERATIONS IN FOREIGN JURISDICTIONS. HOWEVER, THE INSTITUTE'S SCIENTISTS DO TRAVEL TO VARIOUS SCIENTIFIC CONFERENCES IN OTHER COUNTRIES TO SHARE THE INSTITUTE'S SCIENTIFIC DISCOVERIES, AS WELL AS, TO LEARN FROM OTHER SCIENTISTS ACROSS THE WORLD.
SCHEDULE F, PART I, LINE 3, COLUMN ETYPE OF SERVICE SPECIFIC PROGRAM SERVICE ACTIVITY IN ALL REGIONS IS AGENTS ATTENDING AND/OR SPEAKING AT SCIENTIFIC CONFERENCES AND COLLABORATIONS.
SCHEDULE F, PART I, LINE 3, COLUMN EACCOUNTING METHOD THE ACCRUAL METHOD OF ACCOUNTING WAS USED TO DETERMINE THE AMOUNTS INPART I, LINE 3, COLUMN F.

Schedule G IRS990ScheduleG

Fundraiser Activity Info FundraiserActivityInfoGrp (2 entries)

ActivityActivityTxtFundraiser Control Of FundsFundraiserControlOfFundsInd
ED GILLENWATERS
CONSULTINGfalse
BLAIR BLUM PARTNERS
CONSULTINGfalse

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1GALAEvent1Nm
Gross Receipts Event1$877,248GrossReceiptsEvent1Amt
Charitable Contri Event1$832,098CharitableContriEvent1Amt
Gross Revenue Event1$45,150GrossRevenueEvent1Amt
Food And Beverage Event1$65,107FoodAndBeverageEvent1Amt
Entertainment Event1$83,805EntertainmentEvent1Amt
Other Direct Expenses Event1$40,497OtherDirectExpensesEvent1Amt
Other Events Total0OtherEventsTotalCnt
Gross Receipts Total$877,248GrossReceiptsTotalAmt
Charitable Contributions Tot$832,098CharitableContributionsTotAmt
Gross Revenue Total Events$45,150GrossRevenueTotalEventsAmt
Food And Beverage Total Events$65,107FoodAndBeverageTotalEventsAmt
Entertainment Total Events$83,805EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$40,497OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$189,409DirectExpenseSummaryEventsAmt
Net Income Summary-$144,259NetIncomeSummaryAmt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Club Dues Or FeesYes (X)ClubDuesOrFeesInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (true)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (true)SeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (true)SupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (true)AnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
KRISTIINA VUORI MD PHD
PRESIDENT$652,139$0$190,039$0$1,824,711$0$101,500$0$11,145$0$2,779,534$0$1,425,000$0
PERRY NISEN MD PHD
CEO$747,073$0$337,503$0$27,354$0$318,750$0$17,502$0$1,448,182$0$112,500$0
GARY CHESSUM
CFO$325,214$0$0$0$643$0$0$0$5,855$0$331,712$0$0$0
GARY RAISL ED D
EVP/CAO/CFO/TREAS (OUTGOING)$323,243$0$44,341$0$95,891$0$26,500$0$8,330$0$498,305$0$0$0
GARTH POWIS PHD
CENTER DIRECTOR$498,278$0$45,000$0$5,344$0$26,500$0$11,285$0$586,407$0$0$0
DANIEL KELLY MD
CNTR DIR/SCI DIR AT LK NONA$485,987$0$47,380$0$4,250$0$26,500$0$19,218$0$583,335$0$0$0
ZE'EV RONAI
SCIENTIFIC DIRECTOR$300,271$0$29,872$0$3,397$0$26,500$0$17,502$0$377,542$0$0$0
CARL WARE PHD
CENTER DIRECTOR, IIDC$348,942$0$86,485$0$4,427$0$26,500$0$12,571$0$478,925$0$0$0
MICHAEL JACKSON PHD
DRUG DISCOVERY & DEV, SR VP$363,287$0$90,126$0$3,213$0$26,500$0$17,195$0$500,321$0$0$0

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, SCHEDULE J, PART I, LINE 1AFIRST CLASS TRAVEL FIRST CLASS TRAVEL IS GENERALLY NOT PERMITTED, EXCEPT UNDER VERY LIMITED AND RARE CIRCUMSTANCES AND CONDITIONS, SUCH AS A MEDICAL CONDITION REQUIREMENT AND URGENT CIRCUMSTANCES. THIS WAS NOT TREATED AS TAXABLE COMPENSATION. HEALTH OR SOCIAL CLUB DUES HEALTH OR SOCIAL CLUB DUES ARE NEGOTIATED IN THE HIRING PROCESS FOR CERTAIN EMPLOYEES. THE AMOUNTS WERE TREATED AS TAXABLE COMPENSATION.
FORM 990, SCHEDULE J, PART I, LINE 4ADURING THE YEAR THE ORGANIZATION PAID SEVERANCE UNDER A CONFIDENTIAL SEVERANCE AGREEMENT TO ONE INDIVIDUAL.
FORM 990, SCHEDULE J, PART I, LINE 4BSUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN THE PARTICIPANTS OF THE 457(F) DEFERRED COMPENSATION PLAN ARE KRISTIINA VUORI AND PERRY NISEN. VESTING FOR KRISTIINA VUORI OCCURS THE EARLIEST OF 4/1/2020 & PERRY NISEN THE EARLIEST OF 9/15/19, OR INVOLUNTARY TERMINATION WITHOUT CAUSE, OR PARTICIPANT'S RESIGNATION FOR GOOD CAUSE, OR THE DATE OF TERMINATION OF THE PLAN. DISTRIBUTION IS A ONE-TIME LUMP SUM PAYMENT UPON VESTING OF 100% OF THE VALUE OF THE PARTICIPANT'S INVESTMENT (COMPRISED OF INSTITUTE CONTRIBUTIONS TO THE CORPUS PLUS ANY INVESTMENT GAINS OR LOSSES THEREON). DURING 2015, KRISTINA VUORI RECEIVED A PAYMENT FROM THE 457(F) DEFERRED COMPENSATION PLAN OF $1,823,153.
FORM 990, SCHEDULE J, PART I, LINE 7NON-FIXED PAYMENTS SOME SENIOR EXECUTIVES HAVE EMPLOYMENT AGREEMENTS STIPULATING A BONUS WILL BE PAID TO THEM PROVIDED CERTAIN GOALS OR ACCOMPLISHMENTS ARE ACHIEVED.
FORM 990, SCHEDULE J, PART II, COLUMN (C)RETIREMENT AND OTHER DEFERRED COMPENSATION THE AMOUNT REPORTED IN SCHEDULE J, PART II, COLUMN C FOR KRISTIINA VUORI AND PERRY NISEN INCLUDES AN ACCRUAL OF $75,000 AND $300,000 RESPECTIVELY RELATED TO THE 457(F) PLAN DESCRIBED ABOVE. THESE AMOUNTS ARE NOT VESTED AND ARE SUBJECT TO SUBSTANTIAL RISK OF FORFEITURE.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd

Issuer Name IssuerName

FieldValueIRS element (for citing)
Business Name Line1COUNTY OF SAN DIEGOBusinessNameLine1Txt
FieldValueIRS element (for citing)
Bond Issuer EIN956000934BondIssuerEIN
CUSIP79742YAQ5CUSIPNum
Bond Issued2015-11-12BondIssuedDt
Issue Price$61,963,256IssuePriceAmt
PurposeSEE PART VIPurposeDesc
DefeasedfalseDefeasedInd
On Behalf Of IssuerfalseOnBehalfOfIssuerInd
Pool FinancingfalsePoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Retired$0RetiredAmt
Bond Defeased$61,673,870BondDefeasedAmt
Total Proceeds$61,963,256TotalProceedsAmt
In Reserve Fund$0InReserveFundAmt
Capitalized Interest$0CapitalizedInterestAmt
Refunding Escrow$0RefundingEscrowAmt
Issuance Costs From Proceeds$289,386IssuanceCostsFromProceedsAmt
Credit Enhancement$0CreditEnhancementAmt
Working Capital Expenditures$0WorkingCapitalExpendituresAmt
Capital Expenditures$0CapitalExpendituresAmt
Other Spent Proceeds$0OtherSpentProceedsAmt
Unspent$0UnspentAmt
Substantial Completion2015SubstantialCompletionYr
Current RefundingYes (true)CurrentRefundingInd
Advance RefundingfalseAdvanceRefundingInd
Final Allocation MadeYes (true)FinalAllocationMadeInd
Adequate Books And Rec MaintYes (true)AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Owning Bond Financed PropertyfalseOwningBondFinancedPropertyInd
Any Lease ArrangementsYes (true)AnyLeaseArrangementsInd
Mgmt Contract Bond Fincd PropYes (true)MgmtContractBondFincdPropInd
Engage Bond Counsel ContractsYes (true)EngageBondCounselContractsInd
Any Research AgreementsYes (true)AnyResearchAgreementsInd
Engage Bond Counsel ResearchYes (true)EngageBondCounselResearchInd
Private Bus Use By Others0.01600PrivateBusUseByOthersPct
Private Bus Concerning UBI0.00000PrivateBusConcerningUBIPct
Total Private Business Use0.01600TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt TestfalseBondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed PropfalseChangeInUseBondFinancedPropInd
Remedial Action TakenfalseRemedialActionTakenInd
Procs Nonqualified Bond RemdtdfalseProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Form8038 T FiledfalseForm8038TFiledInd
Rebate Not Due YetYes (true)RebateNotDueYetInd
Exception To RebatefalseExceptionToRebateInd
No Rebate DuefalseNoRebateDueInd
Variable Rate IssueYes (true)VariableRateIssueInd
Hedge Identified In Bks And RecfalseHedgeIdentifiedInBksAndRecInd

Hedge Provider Name HedgeProviderName

FieldValueIRS element (for citing)
Business Name Line10BusinessNameLine1Txt
FieldValueIRS element (for citing)
Gross Proceeds Invested In GICfalseGrossProceedsInvestedInGICInd

GIC Provider Name GICProviderName

FieldValueIRS element (for citing)
Business Name Line10BusinessNameLine1Txt
FieldValueIRS element (for citing)
Gross Proceeds InvestedfalseGrossProceedsInvestedInd
Written Proc To Monitor ReqsfalseWrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Procedures Corrective ActionfalseProceduresCorrectiveActionInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE K, PART I, ROW A, COLUMN (F)REFINANCE 2006 AND 2012 BONDS WITH ISSUE DATE 02/01/2006 AND 11/15/2012.
SCHEDULE K, PART I, ROW AFOR THE BOND ISSUE LISTED IN PART I, THE ALTERNATIVE PERIOD USED FOR THE REPORTING REQUIREMENTS IN THIS SECTION IS THE TWELVE MONTHS ENDED DECEMBER 31, 2015.

Schedule L IRS990ScheduleL

Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp (2 entries)

Relationship With OrgRelationshipWithOrgTxtLoan PurposeLoanPurposeTxtLoan From OrganizationLoanFromOrganizationIndOriginal PrincipalOriginalPrincipalAmtBalance DueBalanceDueAmtDefaultDefaultIndBoard Or Committee ApprovalBoardOrCommitteeApprovalIndWritten AgreementWrittenAgreementInd
GARY RAISL
OFFICERQUAL. EMPLOYEE RELOCYes (X)$225,000$207,200falseYes (true)Yes (true)
PERRY NISEN
OFFICERQUAL. EMPLOYEE RELOCYes (X)$1,000,000$977,778falseYes (true)Yes (true)
FieldValueIRS element (for citing)
Total Balance Due$1,184,978TotalBalanceDueAmt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART I, LINE 1 & PART III, LINE 1ORGANIZATIONS MISSION SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CONDUCTS WORLD-CLASS, COLLABORATIVE RESEARCH DEDICATED TO FINDING CURES FOR HUMAN DISEASE, IMPROVING THE QUALITY OF LIFE, AND THUS CREATING A LEGACY FOR ITS EMPLOYEES, PARTNERS, DONORS, AND COMMUNITY.
FORM 990, PART III, LINE 4PROGRAM SERVICE ACCOMPLISHMENTS SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (SBP) IS AN INDEPENDENT NONPROFIT MEDICAL RESEARCH ORGANIZATION THAT CONDUCTS WORLD-CLASS, COLLABORATIVE, BIOLOGICAL RESEARCH AND TRANSLATES ITS DISCOVERIES FOR THE BENEFIT OF PATIENTS. SBP FOCUSES ITS RESEARCH ON CANCER, IMMUNITY, NEURODEGENERATION, METABOLIC DISORDERS AND RARE CHILDRENS DISEASES. CANCER RESEARCH UNCOVERS DEFENDER AGAINST CANCER-PROMOTING LIVER DAMAGE. LIVER CANCER IS ONE OF THE FEW CANCER TYPES FOR WHICH MORTALITY RATES ARE ACTUALLY INCREASING IN THE U.S. MOST CASES ARISE FOLLOWING LIVER DAMAGE BY VIRUSES, ALCOHOL OR FAT ACCUMULATION DUE TO OBESITY. THIS DAMAGE LEADS TO INFLAMMATORY SIGNALS THAT HELP FUEL TUMORS. JORGE MOSCAT, PH.D., AND MARIA DIAZ-MECO, PH.D., PUBLISHED RESEARCH IN 'CANCER CELL' SHOWING HOW A PROTEIN CALLED P62, WHEN LOCATED IN THE TISSUE SURROUNDING A TUMOR, CAN ACTUALLY DAMPEN THE PRODUCTION OF TUMOR-STIMULATING INFLAMMATORY SIGNALS. THE FINDINGS SUGGEST THAT DRUGS AIMED AT INCREASING THE LEVELS OF P62 IN LIVER TISSUE SURROUNDING TUMORS MAY BLOCK LIVER CANCER PROGRESSION. TUMOR SURVIVAL STRATEGY POINTS TO NEW DRUG TARGET. TUMORS HAVE THE UNIQUE ABILITY TO SURVIVE EVEN WHEN SUPPLIES OF OXYGEN ARE LOW - A CONDITION CALLED HYPOXIA - BY PRODUCING A PROTEIN CALLED HYPOXIA INDUCIBLE FACTOR-1 (HIF-1). THOUGH BLOCKING HIF-1 WOULD KILL HYPOXIC TUMORS, FINDING DRUGS THAT ACHIEVE THIS HAS SO FAR PROVEN DIFFICULT. GARTH POWIS, PH.D., PUBLISHED A STUDY IN 'CANCER RESEARCH' THAT INDICATES A WAY AROUND THIS. THE RESEARCH SHOWS THAT ELIMINATING OR BLOCKING AN ENZYME CALLED ALDOLASE A LOWERS ACTIVITY OF HIF-1 AND INHIBITS THE GROWTH OF BREAST CANCER TUMORS. ALDOLASE A IS AN ESPECIALLY PROMISING DRUG TARGET BECAUSE INHIBITING IT WOULD ESSENTIALLY STARVE THE TUMOR. NEW DRUG COMBINATION SHOWS PROMISE AGAINST CHILDHOOD BRAIN CANCER. MEDULLOBLASTOMA IS THE MOST COMMON MALIGNANT BRAIN CANCER IN CHILDREN, BUT SUCCESS RATES FOR TREATING THIS CANCER, DIAGNOSED IN ABOUT 400 CHILDREN PER YEAR IN THE U.S., LAG BEHIND THOSE FOR OTHER PEDIATRIC CANCERS. RESEARCH LED BY ROBERT WECHSLER-REYA, PH.D., USED HIGH-THROUGHPUT SCREENING TO LOOK FOR DRUGS THAT KILL CANCER CELLS FROM THE MOST DEADLY TYPE OF MEDULLOBLASTOMA, CALLED GROUP 3. THIS SCREEN IDENTIFIED A DRUG COMBINATION, HISTONE DEACETYLASE INHIBITORS AND PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS THAT MAY INHIBIT TUMOR GROWTH. THE FINDINGS, PUBLISHED IN 'CANCER CELL', ARE EXPECTED TO LEAD TO A CLINICAL TRIAL SOON BECAUSE BOTH DRUGS ARE ALREADY APPROVED BY THE FDA. SUPER-ONCOGENIC PROTEIN THAT PROMOTES DEVELOPMENT OF MELANOMA. MELANOMA IS THE MOST DEADLY FORM OF SKIN CANCER, CAUSING APPROXIMATELY 10,000 DEATHS PER YEAR IN THE U.S. ZEEV RONAI, PH.D., HAS STUDIED A MELANOMA-PROMOTING PROTEIN CALLED ATF2 FOR DECADES, ILLUSTRATING HOW IT DRIVES CANCER BY REGULATING GENES. HOWEVER, RESEARCH PUBLISHED IN 'CELL REPORTS' SHOWS THAT IN SOME MELANOMAS, ATF2 IS MUTATED IN A WAY THAT MAKES IT UNABLE TO AFFECT GENE ACTIVITY, BUT IT STILL PROMOTES CANCER. THE FINDINGS MAY AID IN THE DEVELOPMENT OF NOVEL THERAPIES FOR MELANOMA DRIVEN BY THIS MUTANT FORM OF ATF2. DISORDERS OF METABOLISM DIABETES DRUGS WEIGHT-LOSS EFFECTS REQUIRE DIFFERENT PARTS OF THE BRAIN THAN PREVIOUSLY THOUGHT. CERTAIN TYPE 2 DIABETES DRUGS CALLED GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1RAS) PROMOTE WEIGHT LOSS, BUT HOW THEY DO THIS REMAINS POORLY UNDERSTOOD. INSIGHT INTO HOW THESE DRUGS WORK IN THE BODY - AND ESPECIALLY THE BRAIN - COULD HELP CREATE NEW DRUGS THAT EFFECTIVELY CONTROL BODY WEIGHT. GLP-1RAS CAUSE PEOPLE TO EAT LESS, AND THEIR WEIGHT LOSS EFFECTS WERE THOUGHT TO RELY ON THE HYPOTHALAMUS, A PART OF THE BRAIN THAT REGULATES APPETITE. JULIO AYALA, PH.D., PUBLISHED A STUDY IN 'DIABETES' SHOWING THAT THE HYPOTHALAMUS ISNT ESSENTIAL FOR GLP-1RAS TO REDUCE FOOD INTAKE. THE FINDINGS INDICATE THAT EFFECTIVE WEIGHT LOSS DRUGS MUST ACT ON OTHER AREAS OF THE BRAIN. GENERATING GOOD FAT BY PUSHING THE RIGHT BUTTONS. AS A WEIGHT LOSS STRATEGY, SCIENTISTS ARE TRYING TO TURN ENERGY-STORING WHITE FAT INTO ENERGY-BURNING BROWN FAT-ESSENTIALLY TURNING IT BEIGE. SHEILA COLLINS, PH.D., PUBLISHED A STUDY IN THE 'JOURNAL OF CLINICAL INVESTIGATION' REVEALING MOLECULAR DETAILS OF HOW THIS CAN HAPPEN. THE PROCESS INVOLVES A SIGNALING PROTEIN CALLED PKA THAT TURNS ON A COMPLEX CALLED MTORC1. THIS FINDING IS SURPRISING BECAUSE MTORC1 IS ALSO ACTIVATED BY GROWTH-PROMOTING SIGNALS LIKE INSULIN, WHILE FAT 'BROWNING' WAS THOUGHT TO OPPOSE GROWTH. THE RESULTS HELP DETERMINE WHICH STEPS COULD BE TARGETED BY FUTURE ANTI-OBESITY DRUGS. FAILING HEARTS SWITCH FUELS TO GENERATE ENERGY. MORE THAN 5 MILLION PEOPLE IN THE UNITED STATES SUFFER FROM HEART FAILURE, ACCORDING TO THE AMERICAN HEART ASSOCIATION, AND LESS THAN HALF SURVIVE FIVE YEARS AFTER DIAGNOSIS. MOST CURRENT TREATMENTS ARE AIMED AT THE LATER STAGES OF DISEASE, BUT RESEARCH FROM DANIEL KELLY, PH.D., PUBLISHED IN 'CIRCULATION', COULD LEAD TO A NEW APPROACH TO TREAT IT EARLIER. THE STUDY FOUND THAT AS THE HEART FAILS, IT LOSES ITS ABILITY TO BURN FATTY ACIDS AND INSTEAD STARTS USING AN ALTERNATIVE ENERGY SOURCE CALLED KETONE BODIES. ITS NOT CLEAR YET WHETHER THIS SWITCH HELPS COMPENSATE FOR DEFECTS OR MAKES THEM WORSE, BUT FURTHER EXPLORATION OF THE ISSUE COULD IDENTIFY NEW THERAPEUTIC TARGETS. FEAST OR FAMINE: THE SWITCH THAT HELPS YOUR LIVER ADAPT. IN METABOLIC CONDITIONS LIKE OBESITY AND DIABETES, THE RESPONSE TO STRESS HORMONES, ALSO CALLED GLUCOCORTICOIDS, IS ALTERED IN WAYS THAT AGGRAVATE DISEASE. THIS INCREASES THE RISK FOR LIVER DISEASE THAT CAN PROGRESS TO FIBROSIS OR LIVER CANCER. TIMOTHY OSBORNE, PH.D., PUBLISHED A STUDY IN 'CELL METABOLISM' SHOWING HOW THE LIVER RESPONDS TO GLUCOCORTICOIDS. BY LOOKING AT GENE ACTIVITY CHANGES ASSOCIATED WITH FASTING, THE RESEARCH IDENTIFIED SETDB2, A GENE THAT ENCODES AN ENZYME THAT CONTROLS WHETHER OTHER GENES CAN BE READ. THE FINDINGS SUGGEST THAT INHIBITING SETDB2 COULD PREVENT THE METABOLIC SIDE EFFECTS OF STEROID MEDICATIONS, SUCH AS WEIGHT GAIN AND INSULIN RESISTANCE. IMMUNITY PROTEIN THAT DIALS IMMUNE RESPONSES UP AND DOWN. RESEARCH LED BY LINDA BRADLEY AND PUBLISHED IN 'IMMUNITY' SHEDS NEW LIGHT ON WHY T CELLS FAIL TO CLEAR CHRONIC INFECTIONS AND ELIMINATE TUMORS. BRADLEYS LAB DISCOVERED A PROTEIN ON THE SURFACE OF T CELLS, P-SELECTIN GLYCOPROTEIN LIGAND-1 (PSGL-1), THAT ACTS AS A NEGATIVE REGULATOR OF T CELL FUNCTION. PSGL-1 IS REQUIRED TO INCREASE LEVELS OF IMMUNE CHECKPOINTS - THE PATHWAYS IN THE IMMUNE SYSTEM THAT KEEP T CELL RESPONSES UNDER CONTROL. THE RESEARCH SUGGESTS THAT PSGL-1 INHIBITORS MAY ENHANCE THE IMMUNE RESPONSE TO CANCER AND CHRONIC VIRAL INFECTIONS SUCH AS HEPATITIS. IT ALSO SUGGESTS THAT BOOSTING PSGL-1 MAY BE A STRATEGY TO TREAT AUTOIMMUNE DISEASES. WHY HIV IS NOT CLEARED BY THE IMMUNE SYSTEM. FOR DECADES, HIV RESEARCHERS HAVE KNOWN THAT THE INITIAL IMMUNE RESPONSE TO HIV FAILS TO PREVENT THE VIRUS FROM REPLICATING, BUT THE REASONS WHY WERE UNCLEAR. SUMIT CHANDA, PH.D., PUBLISHED A PAPER IN 'CELL HOST & MICROBE' SHOWING THAT A PROTEIN IN IMMUNE CELLS CALLED NLRX1 ACTUALLY REPRESSES THE INITIAL IMMUNE RESPONSE TRIGGERED BY VIRAL DNA. THE DISCOVERY COULD LEAD TO BETTER ANTIVIRAL DRUGS OR WAYS TO IMPROVE VACCINES AGAINST HIV OR OTHER VIRUSES. IT COULD ALSO INFORM THE DEVELOPMENT OF FUTURE CANCER THERAPIES BECAUSE NLRX1 IS PART OF A SIGNALING PATHWAY THAT CAN ENHANCE IMMUNE RESPONSES AGAINST CANCER CELLS. NEUROSCIENCE AND AGING POTENTIAL WAY TO SLOW ADVANCE OF ALZHEIMERS. HUAXI XU, PH.D., HAS PUBLISHED RESEARCH IN 'THE JOURNAL OF NEUROSCIENCE' THAT SUGGESTS A NEW WAY TO MINIMIZE THE GENERATION OF AMYLOID-BETA AND SLOW THE ADVANCE OF ALZHEIMERS DISEASE. DEPOSITS OF AMYLOID-BETA IN THE BRAIN ARE A PATHOGENIC HALLMARK OF ALZHEIMERS DISEASE. THE STUDY FOUND THAT A RECEPTOR CALLED SORLA, WITH ITS PARTNER SNX27, MOVES THE AMYLOID PRECURSOR PROTEIN AWAY FROM THE ACIDIC COMPARTMENT, WHERE IT IS PROCESSED INTO AMYLOID BETA, TO A DIFFERENT LOCATION WHERE IT CANNOT BE CUT. MODULATING THE TRAFFICKING OF THE AMYLOID PRECURSOR PROTEIN THROUGH SORLA MAY BE A NEW THERAPEUTIC APPROACH FOR ALZHEIMERS DISEASE. DIETARY RESTRICTION INCREASES LIFESPAN THROUGH EFFECTS ON THE GUT. DIETARY RESTRICTION LENGTHENS HEALTHY LIFESPAN IN MANY SPECIES, INCLUDING HUMANS. EATING LESS INCREASES THE RATE AT WHICH CELLS RECYCLE THEIR COMPONENTS BY A PROCESS CALLED AUTOPHAGY. TO DETERMINE IN WHICH ORGANS AUTOPHAGY MATTERS MOST, MALENE HANSEN, PH.D., BLOCKED AUTOPHAGY IN THE INTESTINES OF TINY WORMS CALLED C. ELEGANS, AND FOUND THAT DIETARY RESTRICTION NO LONGER EXTENDED LIFESPAN. THE RESULTS, PUBLISHED IN 'PLOS GENETICS', SHOW THAT AUTOPHAGY IN THE GUT IS ESSENTIAL TO PRESERVE ITS BARRIER FUNCTION, WHICH PREVENTS HARMFUL MICROBES AND TOXINS FROM REACHING THE REST OF THE BODY. THE FINDINGS COULD EVENTUALLY LEAD TO NEW TREATMENTS THAT HELP PEOPLE LIVE LONGER, HEALTHIER LIVES. SCIENTIFIC BREAKTHROUGH MAY LIMIT DAMAGE CAUSED BY HEART ATTACKS. HEART ATTACKS DESTROY H
FORM 990, PART VI, LINE 11BPROCESS USED BY MANAGEMENT AND/OR GOVERNING BODY TO REVIEW FORM 990 THE 990 IS PREPARED BY THE FINANCE DEPARTMENT. IT IS REVIEWED BY THE INSTITUTE'S TAX ADVISORS, SELECTED MEMBERS OF MANAGEMENT INCLUDING THE CHIEF FINANCIAL OFFICER AND THE AUDIT COMMITTEE OF THE BOARD OF TRUSTEES AND PROVIDED TO MEMBERS OF THE BOARD PRIOR TO FILING.
FORM 990, PART VI, LINE 12CDESCR OF PROCESS TO MONITOR TRANSACTIONS FOR CONFLICT OF INTEREST CONFLICT OF INTEREST STATEMENTS ARE GIVEN TO MANAGEMENT STAFF AND PRINCIPAL INVESTIGATORS ON A PERIODIC BASIS TO REPORT ON CONFLICTS OR LACK OF CONFLICTS. THE STATEMENTS ARE REVIEWED ANNUALLY BY THE SENIOR DIRECTOR, INTELLECTUAL PROPERTY AND THE SENIOR DIRECTOR, SPONSORED RESEARCH, WITH A SUMMARY OF THE REVIEW PROVIDED TO THE CFO. AN ASSESSMENT IS MADE AS TO WHETHER A CONFLICT CAN BE MANAGED BY THE EXISTING DEPARTMENTS AND PRACTICES. CONFLICTS ARE BROUGHT TO THE BOARD OF TRUSTEES ON AN AS NEEDED BASIS. CONFLICTS AND POTENTIAL CONFLICTS THAT INVOLVE THE CEO OR THE PRESIDENT ARE BROUGHT TO THE BOARD OF TRUSTEES TO ADDRESS ANY ACTUAL OR POTENTIAL POSSIBILITY THAT THE DESIGNATED REVIEWERS (I.E., SENIOR DIRECTOR, INTELLECTUAL PROPERTY AND THE SENIOR DIRECTOR, SPONSORED RESEARCH, AND THE CFO) COULD BE PRESSURED TO MAKE BIASED DECISIONS IN MANAGING CONFLICTS INVOLVING THE CEO OR PRESIDENT. AS TO RESTRICTIONS IMPOSED: THE INSTITUTE WILL EMPLOY THE MECHANISM THAT IS THE BEST FIT WITH THE FACTS AND CIRCUMSTANCES OF ANY IDENTIFIED CONFLICT OF INTEREST. METHODS TO MANAGE POTENTIAL CONFLICTS/ENFORCEMENT MECHANISM: REVIEWING MANAGEMENT IS RESPONSIBLE FOR MANAGING, REDUCING, OR ELIMINATING REAL OR POTENTIAL CONFLICTS OF INTEREST. EXAMPLES OF CONDITIONS OR RESTRICTIONS THAT MIGHT BE IMPOSED TO MANAGE, REDUCE, OR ELIMINATE CONFLICTS OF INTERESTS INCLUDE: -PUBLIC DISCLOSURE OF SIGNIFICANT FINANCIAL INTERESTS -MONITORING OF RESEARCH BY INDEPENDENT REVIEWERS -MODIFICATION OF THE RESEARCH PLAN -DISQUALIFICATION FROM PARTICIPATION IN THE PORTION OF FUNDED RESEARCH THAT COULD BE AFFECTED BY SIGNIFICANT FINANCIAL INTEREST -DIVESTITURE OF SIGNIFICANT FINANCIAL INTERESTS -SEVERANCE OF RELATIONSHIPS THAT CREATE ACTUAL OR POTENTIAL CONFLICTS -REVIEW OF COMMERCIAL SPONSORED RESEARCH AGREEMENTS FOR SCIENTIFIC MERIT BY THE PROGRAM PLANNING COMMITTEE -REMOVAL OF AN AFFECTED PARTY FROM NEGOTIATION WITH A COMPANY WITH WHICH HE/SHE HAS SIGNIFICANT FINANCIAL INTEREST.
FORM 990, PART VI, LINE 15A & 15BPROCESS FOR DETERMINING COMPENSATION COMPENSATION FOR THE CEO, THE PRESIDENT, CHIEF FINANCIAL OFFICER, AND OTHER KEY EMPLOYEES IS ESTABLISHED ACCORDING TO INSTITUTE POLICIES WHICH ARE DESIGNED TO MEET THE IRS STANDARD FOR "REBUTTABLE PRESUMPTION OF REASONABLENESS". THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES, CONSISTING OF FOUR INDEPENDENT TRUSTEES, REVIEWS COMPARABILITY DATA PROVIDED BY AN INDEPENDENT EXTERNAL CONSULTANT THAT INCORPORATES AND EVALUATES INSTITUTE DATA AND THAT OF COMPARABLE ORGANIZATIONS AND MARKETS FROM WHICH THE INSTITUTE DRAWS ITS EXECUTIVE TALENT. UTILIZING THIS INFORMATION, THE COMPENSATION COMMITTEE, WHICH TYPICALLY SEEKS TO ESTABLISH COMPENSATION BETWEEN THE 50TH AND THE 75TH PERCENTILE OF THE COMPARABILITY DATA, MAKES A DETERMINATION WHETHER THE PROPOSED COMPENSATION IS REASONABLE. THE COMPENSATION COMMITTEE HAS BEEN DELEGATED AUTHORITY BY THE BOARD OF TRUSTEES TO REVIEW AND APPROVE COMPENSATION OF ALL POSITIONS EXCEPT FOR THE CEO. THE CEOS COMPENSATION PACKAGE IS REVIEWED AND APPROVED INITIALLY BY THE COMPENSATION COMMITTEE AND THEN GOES TO THE EXECUTIVE COMMITTEE FOR FINAL APPROVAL. THE COMPENSATION COMMITTEE CONTEMPORANEOUSLY AND ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION AND RECOMMENDATION TO THE EXECUTIVE COMMITTEE. IF APPROVED BY THE EXECUTIVE COMMITTEE, THE CEO COMPENSATION PACKAGE IS THEN IMPLEMENTED AND SUCH DOCUMENTATION IS KEPT IN THE WRITTEN AND ELECTRONIC RECORDS OF THE BOARD OF TRUSTEES. THE PROCESS WAS LAST COMPLETED ON MAY 25, 2016 FOR THE FOLLOWING POSITIONS: 1) CEO 2) PRESIDENT 3) CFO 4) SVP HUMAN RESOURCES 5) VP STRATEGIC ALLIANCE 6) SVP DRUG DISCOVERY & DEVELOPMENT 7) SCIENTIFC DIRECTOR/PROFESSOR 8) CENTER DIRECTOR, LA JOLLA PROFESSOR 9) INFECTIOUS & INFLAMMATORY DISEASE CENTER DIRECTOR/PROFESSOR
FORM 990, PART VI, LINE 19PROCESS FOR MAKING DOCUMENTS AVAILABLE TO THE PUBLIC DOCUMENTS ARE AVAILABLE UPON REQUEST.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1FL MED DISCOVERY INSTITUTE AT LAKE NONABusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line110901 N TORREY PINES ROADAddressLine1Txt
CityLA JOLLACityNm
State AbbreviationCAStateAbbreviationCd
ZIP92037ZIPCd
FieldValueIRS element (for citing)
EIN474997825EIN
Primary ActivitiesRESEARCHPrimaryActivitiesTxt
Legal Domicile StateCALegalDomicileStateCd
Exempt Code Section501(C)(3)ExemptCodeSectionTxt
Public Charity Status7PublicCharityStatusTxt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1SBPMDIBusinessNameLine1Txt
FieldValueIRS element (for citing)
Controlled OrganizationYes (true)ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsfalseReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgfalseGiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgfalseGiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgfalseLoansOrGuaranteesFromOthOrgInd
Div Related OrganizationfalseDivRelatedOrganizationInd
Asset Sale To Other OrgfalseAssetSaleToOtherOrgInd
Asset Purchase From Other OrgfalseAssetPurchaseFromOtherOrgInd
Asset ExchangefalseAssetExchangeInd
Rental Of Facilities To Oth OrgfalseRentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgfalseRentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgfalsePerformOfServicesForOthOrgInd
Perform Of Services By Other OrgfalsePerformOfServicesByOtherOrgInd
Sharing Of FacilitiesfalseSharingOfFacilitiesInd
Paid Employees SharingfalsePaidEmployeesSharingInd
Reimbursement Paid To Other OrgfalseReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgfalseReimbursementPaidByOtherOrgInd
Transfer To Other OrgfalseTransferToOtherOrgInd
Transfer From Other OrgfalseTransferFromOtherOrgInd